Atlas Trials

Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes

Clinical trial NCT07387003 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07387003
Sponsor
Gan & Lee Pharmaceuticals.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes (T2DM)
Start date
2026-04-10
Primary completion
2027-02-11
Enrollment
345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.